Format
Items per page
Sort by

Send to:

Choose Destination

Search results

Items: 1 to 20 of 21

1.

Emergence and Dissemination of ST131 Escherichia coli Isolates Among Patients with Hospital-Acquired Pneumonia in Asian Countries.

Cha MK, Kang CI, Kim SH, Thamlikitkul V, So TM, Ha YE, Chung DR, Peck KR, Song JH.

Microb Drug Resist. 2016 Apr 20. [Epub ahead of print]

PMID:
27096168
2.

In vitro activity of Tedizolid phosphate against multidrug-resistant Streptococcus pneumoniae isolates from Asian countries.

Baek JY, Kang CI, Kim SH, Ko KS, Chung DR, Peck KR, Hsueh PR, Thamlikitkul V, So TM, Lee NY, Song JH; ANSORP Study Group.

Diagn Microbiol Infect Dis. 2016 Mar 2. pii: S0732-8893(16)30038-4. doi: 10.1016/j.diagmicrobio.2016.02.022. [Epub ahead of print]

PMID:
27083121
3.

Prevalence and characteristics of Streptococcus pneumoniae "putative serotype 6E" isolates from Asian countries.

Baek JY, Park IH, So TM, Lalitha MK, Shimono N, Yasin RM, Carlos CC, Perera J, Thamlikitkul V, Hsueh PR, Van PH, Shibl AM, Song JH, Ko KS.

Diagn Microbiol Infect Dis. 2014 Dec;80(4):334-7.

PMID:
25439447
4.

Early Viral Kinetics with Telbivudine, Tenofovir or Combination of Both in Immunotolerant Patients with Hepatitis B e Antigen-Positive Chronic Hepatitis B.

Leung NW, Herrmann E, Lau GK, Chan HL, So TM, Zeuzem S, Dong Y, Trylesinski A, Naoumov NV.

Infect Dis Ther. 2014 Dec;3(2):191-202. doi: 10.1007/s40121-014-0039-5. Epub 2014 Sep 17.

5.

Risk factors for levofloxacin-nonsusceptible Streptococcus pneumoniae in community-acquired pneumococcal pneumonia: a nested case-control study.

Kang CI, Song JH, Kim SH, Chung DR, Peck KR, So TM, Hsueh PR; ANSORP Study Group.

Eur J Clin Microbiol Infect Dis. 2014 Jan;33(1):55-9. doi: 10.1007/s10096-013-1928-3. Epub 2013 Sep 6.

PMID:
24062235
6.

Spread of carbapenem-resistant Acinetobacter baumannii global clone 2 in Asia and AbaR-type resistance islands.

Kim DH, Choi JY, Kim HW, Kim SH, Chung DR, Peck KR, Thamlikitkul V, So TM, Yasin RM, Hsueh PR, Carlos CC, Hsu LY, Buntaran L, Lalitha MK, Song JH, Ko KS.

Antimicrob Agents Chemother. 2013 Nov;57(11):5239-46. doi: 10.1128/AAC.00633-13. Epub 2013 Aug 12.

7.

Risk factors and pathogenic significance of bacteremic pneumonia in adult patients with community-acquired pneumococcal pneumonia.

Kang CI, Song JH, Kim SH, Chung DR, Peck KR, Thamlikitkul V, Wang H, So TM, Hsueh PR, Yasin RM, Carlos CC, Van PH, Perera J.

J Infect. 2013 Jan;66(1):34-40. doi: 10.1016/j.jinf.2012.08.011. Epub 2012 Aug 23.

PMID:
22922634
8.

Association of levofloxacin resistance with mortality in adult patients with invasive pneumococcal diseases: a post hoc analysis of a prospective cohort.

Kang CI, Song JH, Kim SH, Chung DR, Peck KR, Thamlikitkul V, Wang H, So TM, Hsueh PR, Yasin RM, Carlos CC, Van PH, Perera J; Asian Network for Surveillance of Resistant Pathogens (ANSORP) Study Group.

Infection. 2013 Feb;41(1):151-7. doi: 10.1007/s15010-012-0299-5. Epub 2012 Jul 22.

PMID:
22821428
9.

Changing trends in antimicrobial resistance and serotypes of Streptococcus pneumoniae isolates in Asian countries: an Asian Network for Surveillance of Resistant Pathogens (ANSORP) study.

Kim SH, Song JH, Chung DR, Thamlikitkul V, Yang Y, Wang H, Lu M, So TM, Hsueh PR, Yasin RM, Carlos CC, Pham HV, Lalitha MK, Shimono N, Perera J, Shibl AM, Baek JY, Kang CI, Ko KS, Peck KR; ANSORP Study Group.

Antimicrob Agents Chemother. 2012 Mar;56(3):1418-26. doi: 10.1128/AAC.05658-11. Epub 2012 Jan 9.

10.

High prevalence of multidrug-resistant nonfermenters in hospital-acquired pneumonia in Asia.

Chung DR, Song JH, Kim SH, Thamlikitkul V, Huang SG, Wang H, So TM, Yasin RM, Hsueh PR, Carlos CC, Hsu LY, Buntaran L, Lalitha MK, Kim MJ, Choi JY, Kim SI, Ko KS, Kang CI, Peck KR; Asian Network for Surveillance of Resistant Pathogens Study Group.

Am J Respir Crit Care Med. 2011 Dec 15;184(12):1409-17. doi: 10.1164/rccm.201102-0349OC. Epub 2011 Sep 15.

PMID:
21920919
11.

Spread of methicillin-resistant Staphylococcus aureus between the community and the hospitals in Asian countries: an ANSORP study.

Song JH, Hsueh PR, Chung DR, Ko KS, Kang CI, Peck KR, Yeom JS, Kim SW, Chang HH, Kim YS, Jung SI, Son JS, So TM, Lalitha MK, Yang Y, Huang SG, Wang H, Lu Q, Carlos CC, Perera JA, Chiu CH, Liu JW, Chongthaleong A, Thamlikitkul V, Van PH; ANSORP Study Group.

J Antimicrob Chemother. 2011 May;66(5):1061-9. doi: 10.1093/jac/dkr024. Epub 2011 Feb 20.

12.

Clinical impact of methicillin resistance on outcome of patients with Staphylococcus aureus infection: a stratified analysis according to underlying diseases and sites of infection in a large prospective cohort.

Kang CI, Song JH, Chung DR, Peck KR, Ko KS, Yeom JS, Kim SW, Chang HH, Kim YS, Jung SI, Son JS, Hsueh PR, So TM, Lalitha MK, Yang Y, Huang SG, Wang H, Lu Q, Carlos CC, Perera JA, Chiu CH, Liu JW, Chongthaleong A, Thamlikitkul V, Van Pham H; Asian Network for Surveillance of Resistant Pathogens (ANSORP) Study Group.

J Infect. 2010 Oct;61(4):299-306. doi: 10.1016/j.jinf.2010.07.011. Epub 2010 Jul 27.

PMID:
20670652
13.

Economic evaluation of universal infant vaccination with 7vPCV in Hong Kong.

Lee KK, Rinaldi F, Chan MK, Chan ST, So TM, Hon EK, Lee VW.

Value Health. 2009 Nov-Dec;12 Suppl 3:S42-8. doi: 10.1111/j.1524-4733.2009.00626.x.

14.

Significance of the myxovirus resistance A (MxA) gene -123C>a single-nucleotide polymorphism in suppressed interferon beta induction of severe acute respiratory syndrome coronavirus infection.

Ching JC, Chan KY, Lee EH, Xu MS, Ting CK, So TM, Sham PC, Leung GM, Peiris JS, Khoo US.

J Infect Dis. 2010 Jun 15;201(12):1899-908. doi: 10.1086/652799.

15.

CD209 (DC-SIGN) -336A>G promoter polymorphism and severe acute respiratory syndrome in Hong Kong Chinese.

Chan KY, Xu MS, Ching JC, So TM, Lai ST, Chu CM, Yam LY, Wong AT, Chung PH, Chan VS, Lin CL, Sham PC, Leung GM, Peiris JS, Khoo US.

Hum Immunol. 2010 Jul;71(7):702-7. doi: 10.1016/j.humimm.2010.03.006. Epub 2010 May 4.

PMID:
20359516
16.

Health-related quality of life of Southern Chinese with chronic hepatitis B infection.

Lam ET, Lam CL, Lai CL, Yuen MF, Fong DY, So TM.

Health Qual Life Outcomes. 2009 Jun 5;7:52. doi: 10.1186/1477-7525-7-52.

17.

Sustained HBeAg and HBsAg loss after long-term follow-up of HBeAg-positive patients treated with peginterferon alpha-2b.

Buster EH, Flink HJ, Cakaloglu Y, Simon K, Trojan J, Tabak F, So TM, Feinman SV, Mach T, Akarca US, Schutten M, Tielemans W, van Vuuren AJ, Hansen BE, Janssen HL.

Gastroenterology. 2008 Aug;135(2):459-67. doi: 10.1053/j.gastro.2008.05.031. Epub 2008 May 15.

PMID:
18585385
18.

Peg-interferon improves liver histology in patients with HBeAg-positive chronic hepatitis B: no additional benefit of combination with lamivudine.

van Zonneveld M, Zondervan PE, Cakaloglu Y, Simon C, Akarca US, So TM, Flink HJ, de Man RA, Schalm SW, Janssen HL; HBV 99-01 Study Group.

Liver Int. 2006 May;26(4):399-405.

PMID:
16629642
19.

The safety of pegylated interferon alpha-2b in the treatment of chronic hepatitis B: predictive factors for dose reduction and treatment discontinuation.

van Zonneveld M, Flink HJ, Verhey E, Senturk H, Zeuzem S, Akarca US, Cakaloglu Y, Simon C, So TM, Gerken G, de Man RA, Hansen BE, Schalm SW, Janssen HL; HBV 99-01 Study Group.

Aliment Pharmacol Ther. 2005 May 1;21(9):1163-71.

20.

Pegylated interferon alfa-2b alone or in combination with lamivudine for HBeAg-positive chronic hepatitis B: a randomised trial.

Janssen HL, van Zonneveld M, Senturk H, Zeuzem S, Akarca US, Cakaloglu Y, Simon C, So TM, Gerken G, de Man RA, Niesters HG, Zondervan P, Hansen B, Schalm SW; HBV 99-01 Study Group; Rotterdam Foundation for Liver Research.

Lancet. 2005 Jan 8-14;365(9454):123-9.

PMID:
15639293
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk